Cita APA

Dix, D. B., Fernandez, C. V., Chi, Y., Mullen, E. A., Geller, J. I., Gratias, E. J., . . . Dome, J. S. (2019). Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children’s Oncology Group AREN0532 and AREN0533 Study Report. J Clin Oncol.

Chicago Style Citation

Dix, David B., et al. "Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children’s Oncology Group AREN0532 and AREN0533 Study Report." J Clin Oncol 2019.

Cita MLA

Dix, David B., et al. "Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children’s Oncology Group AREN0532 and AREN0533 Study Report." J Clin Oncol 2019.